drugset / Trial / NCT01159626
Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
This Phase 1 study is the first clinical trial in Japanese subjects. The study is designed to evaluate the single- and multiple-dose pharmacokinetics, safety and tolerability of PF-03463275 oral controlled release formulation in Japanese and Western male subjects.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-03463275 | Small molecule | 20 mg | Oral |
| Subject | PF-03463275 | Small molecule | 40 mg | Oral |
| Subject | PF-03463275 | Small molecule | 60 mg | Oral |
Indications
No indication recorded.